Defective membrane repair in dysferlin-deficient muscular dystrophy

Dystrophin protects the sarcolemma from stresses developed during muscle contraction

Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., & Sweeney, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3710 · Cited by 1,526

Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes

Reddy, A. J., Caler, E. V., & Andrews, N. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00421-4 · Cited by 1,043

Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle

Ervasti, J. M., Ohlendieck, K., Kahl, S. D., Gaver, M. G., & Campbell, K. P. (1990) · Nature · doi:10.1038/345315a0 · Cited by 1,033

Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy

Liu, J., Aoki, M., Illa, I., Wu, C., Fardeau, M., Angelini, C. I., Serrano, C., Urtizberea, J. A., Hentati, F., Hamida, M. B., et al. (1998) · Nature Genetics · doi:10.1038/1682 · Cited by 919

A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B

Bashir, R., Britton, S., Strachan, T., Keers, S. M., Vafiadaki, E., Lako, M., Richard, I., Marchand, S., Bourg, N., Argov, Z., et al. (1998) · Nature Genetics · doi:10.1038/1689 · Cited by 685

The Laminin α Chains: Expression, Developmental Transitions, and Chromosomal Locations of α1-5, Identification of Heterotrimeric Laminins 8–11, and Cloning of a Novel α3 Isoform

Miner, J. H., Patton, B. L., Lentz, S. I., Gilbert, D. J., Snider, W. D., Jenkins, N. A., Copeland, N. G., & Sanes, J. R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.3.685 · Cited by 650

Molecular basis of muscular dystrophies

Cohn, R. D., & Campbell, K. P. (2000) · Muscle & Nerve · doi:10.1002/1097-4598(200010)23:10 · Cited by 538

Cell Membrane Resealing by a Vesicular Mechanism Similar to Neurotransmitter Release

Steinhardt, R. A., Bi, G., & Alderton, J. M. (1994) · Science · doi:10.1126/science.7904084 · Cited by 530

Animal models for muscular dystrophy show different patterns of sarcolemmal disruption

Straub, V., Rafael, J. A., Chamberlain, J. S., & Campbell, K. P. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.2.375 · Cited by 488

Muscular dystrophies involving the dystrophin–glycoprotein complex: an overview of current mouse models

Durbeej, M., & Campbell, K. P. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00309-x · Cited by 434

Gene co-expression network analysis of dysferlinopathy: Altered cellular processes and functional prediction of TOR1AIP1, a novel muscular dystrophy gene

Daylan, A. E. C., & Dinçer, P. (2016) · Neuromuscular Disorders · doi:10.1016/j.nmd.2016.10.011 · Cited by 3

Conventional and Secretory Lysosomes

Shrestha, R., Kaplan, J., & Ward, D. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.20019-9 · Cited by 3

The Functional Consequences of Dystrophin Deficiency in Skeletal Muscles

Gillis, J. (2007) · Springer eBooks · doi:10.1007/978-0-387-36534-3_20 · Cited by 3

Apolipoprotein E knockout, but not cholesteryl ester transfer protein (CETP)-associated high-density lipoprotein cholesterol (HDL-C) lowering, exacerbates muscle wasting in dysferlin-null mice

Sun, Z., White, Z. R., Théret, M., & Bernatchez, P. N. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02227-5 · Cited by 2

Performance of upper limb entry item to predict forced vital capacity in dysferlin-deficient limb girdle muscular dystrophy

Borland, H., Moore, U., Dressman, H. G., Human, A., Mayhew, A. G., Hilsden, H., Rufibach, L., Duong, T., Maron, E., DeWolf, B., et al. (2024) · Neuromuscular Disorders · doi:10.1016/j.nmd.2024.08.003 · Cited by 2

Dysferlinopathy as cause of long-term hyperCKemia with preserved strength

Cheema, I., Goodwin, J., Liewluck, T., Bucelli, R. C., Pestronk, A., & Milone, M. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03850-w · Cited by 2

Whole Exome Sequencing Identified a Stop‐Gained Mutation in DYSF Gene Associated With Dysferlinopathy in an Iranian Family

Baghshomali, S., Jebelli, A., Kazemzadeh, M., Jalalypour, F., Yazdchi, M., Mokhtarzadeh, A., & Emrahi, L. (2025) · International Journal of Genomics · doi:10.1155/ijog/9103068 · Cited by 2

Dysferlin Protein–Protein Interaction Pathways in the Organ of Corti and Spiral Ganglion Intersect with Alzheimer’s Protein Pathways

Drescher, M. J., Drescher, D. G., Khan, K. M., Hatfield, J. S., & Hemani, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199559 · Cited by 2

Reasons for misdiagnosis of polymyositis in patients with dysferlinopathy: a clinical case

Bardakov, S. N., Emelin, A. M., Nikitin, S. S., Khelkovskaya-Sergeeva, A. N., Limaev, I. S., Murtazina, A. F., Tsargush, V. A., Gusev, M. V., Safronova, Y. V., Kaimonov, V., et al. (2022) · Neuromuscular Diseases · doi:10.17650/2222-8721-2022-12-4-73-87 · Cited by 2

A female case report of LGMD2B with compound heterozygous mutations of the DYSF gene and asymptomatic mutation of the X-linked DMD gene

Cao, X., Zeng, L., Lu, Z., Fan, J., Tan, S., Zhang, M., & Yin, Z. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1213090 · Cited by 2

Antisense oligonucleotide-mediated exon 27 skipping restores dysferlin function in dysferlinopathy patient-derived muscle cells

Anwar, S., Roshmi, R. R., Woo, S., Haque, U. S., Lee, J. J. A., Duddy, W. J., Bigot, A., Maruyama, R., & Yokota, T. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102443 · Cited by 2

Zebrafish Models of Muscular Dystrophies and Congenital Myopathies

Mitsuhashi, H. (2018) · Springer eBooks · doi:10.1007/978-981-13-1879-5_10 · Cited by 2

ANO5 in membrane repair - Status: “It’s complicated”

Gerke, V., & Rescher, U. (2021) · Cell Calcium · doi:10.1016/j.ceca.2021.102415 · Cited by 2

The Donnan-dominated resting state of skeletal muscle fibers contributes to resilience and longevity in dystrophic fibers

Morris, C. E., Wheeler, J. J., & Joós, B. (2021) · The Journal of General Physiology · doi:10.1085/jgp.202112914 · Cited by 2

Metabolic dysregulation contributes to the development of dysferlinopathy

Furrer, R., Dilbaz, S., Steurer, S. A., Santos, G., Karrer‐Cardel, B., Ritz, D., Sinnreich, M., & Handschin, C. (2025) · Life Science Alliance · doi:10.26508/lsa.202402991 · Cited by 2

The invasion pore induced by Toxoplasma gondii

Kegawa, Y., Male, F., Jiménez-Munguía, I., Blank, P. S., Mekhedov, E., Ward, G. E., & Zimmerberg, J. J. (2025) · EMBO Reports · doi:10.1038/s44319-025-00565-8 · Cited by 2

Mutation at a new allele of the dysferlin gene causes Miyoshi myopathy: A case report.

Yan, H., Xie, Y.-N., Han, J., & Song, X.-Q. (2021) · PubMed Central · Cited by 2

Biology and research applications

Bräutigam, L., & Filipek‐Górniok, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821099-4.00013-4 · Cited by 2

Evaluation of cardiomyopathy with two‐dimensional speckle tracking echocardiography in limb‐girdle muscular dystrophy type 2A and 2B

Akyüz, A., Çap, M., Varsak, S., Işık, F., Türken, A., Taştan, E., & Baysal, E. (2022) · Journal of Clinical Ultrasound · doi:10.1002/jcu.23323 · Cited by 2

Limb-Girdle Muscular Dystrophy Type 2B (LGMD2B) Caused by Pathogenic Splice and Missense Variants of DYSF Gene Among Iranians with Muscular Dystrophy

Arab, ‬., Ahangari, N., Malek, H., Doosti, M., Torbati, P. N., & Karimiani, E. G. (2023) · Advanced Biomedical Research · doi:10.4103/abr.abr_131_22 · Cited by 2

Preand posttranscriptional genetic information modification in muscular dystrophy treatment

Антонович, Я. И., Deev, R. V., Solovyeva, V. V., Rizvanov, A. A., & Isaev, A. A. (2016) · Genes and Cells · doi:10.23868/gc120570 · Cited by 2

Description of muscle disease – specific diseases

Karpati, G. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.014 · Cited by 2

Advances in the Understanding of Skeletal Myopathies from Zebrafish Models

Baxter, E. C., & Bryson‐Richardson, R. J. (2018) · Springer eBooks · doi:10.1007/978-981-13-1879-5_9 · Cited by 2

Effects of Prednisone on a Patient with Dysferlinopathy Assessed by Maximal Voluntary Isometric Contraction: Alternate-Day Low-Dose Administration for a 17-Year Period

Takahashi, K. (2019) · Case Reports in Neurology · doi:10.1159/000495746 · Cited by 2

Dysferlin-deficient myotubes show tethering of different membrane compartments characterized by TMEM16E and DHPRα

Kubozono, K., Mizuta, K., Fujimoto, S., Tran, T. T., Kamata, N., & Tobiume, K. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.06.079 · Cited by 2

Muscular Dystrophies

Escolar, D. M., & Leshner, R. T. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00093-7 · Cited by 2

Organization of Ca2+ Signaling Microdomains in Cardiac Myocytes

Li, J., Richmond, B., & Hong, T. (2022) · Springer eBooks · doi:10.1007/978-3-031-08309-9_2 · Cited by 3

Effects of wounds in the cell membrane on cell division

Tanvir, M. I. O., & Yumura, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-28339-z · Cited by 2

Muscular Dystrophies

Lim, L. E., Thornton, C. A., & Rando, T. A. (2007) · Elsevier eBooks · doi:10.1016/b978-012088592-3/50086-4 · Cited by 2

The effect of taurine on dystrophic muscle tissue function

Horvath, D. (2011) · Victoria University Research Repository (Victoria University) · Cited by 2

MOLECULAR GENETICS OF TIBIAL MUSCULAR DYSTROPHY (TMD) AND A NOVEL DISTAL MYOPATHY

Haravuori, H. (2003) · Työväentutkimus Vuosikirja · Cited by 2

The Physiological and Genetic Factors Underpinning the Response to Muscle Damaging Exercise

Baumert, P. (2019) · Liverpool John Moores University · doi:10.24377/ljmu.t.00010325 · Cited by 2

Increased remodeling and impaired adaption to endurance exercise in desminopathyPreprint

Mossakowski, A. A., Langer, H. T., Bizieff, A., Avey, A. M., Zbinden‐Foncea, H., Hellerstein, M. K., & Baar, K. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.03.462939 · Cited by 2

Synergism and chemiluminescence of cerium ions and ruthenium complexes in the belousov-zhabotinskii reaction

Karavaev, A. D., Kazakov, V. P., & Толстиков, Г. А. (1986) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 2

Pathogenic Mutations in the C2A Domain of Dysferlin form Amyloid that Activates the InflammasomePreprint

Scott, I. L., Dominguez, M. J., Snow, A., Harsini, F. M., Williams, J., Fuson, K. L., Thapa, R., Bhattacharjee, P., Cornwall, G. A., Keyel, P. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.24.538129 · Cited by 2

Satellite Cells in Regeneration and DiseasePreprint

Esper, M. E., Saber, J., & Rudnicki, M. A. (2025) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041474 · Cited by 2

Novel five nucleotide deletion in dysferlin leads to autosomal recessive limb‐girdle muscular dystrophy

Chen, Y., Wu, W., Wang, P., Yip, P., Wu, Y., Lin, Y., & Lin, W. (2023) · Physiological Reports · doi:10.14814/phy2.15887 · Cited by 1

Dysferlin’s C2A domain supports normal Ca2+ signaling and membrane repair in dysferlin-null myofibers

Lukyanenko, V. I., Muriel, J. M., Banford, K. K., Kwiatkowski, T. A., Bulgart, H. R., Weisleder, N. L., & Bloch, R. J. (2026) · The Journal of General Physiology · doi:10.1085/jgp.202513844 · Cited by 1

Wound Repair of the Cell Membrane: Lessons from Dictyostelium Cells

Yumura, S. (2024) · Cells · doi:10.3390/cells13040341 · Cited by 1

Antisense oligonucleotide-mediated exon 27 skipping restores dysferlin function in dysferlinopathy patient-derived muscle cells

Suzuki, N. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102462 · Cited by 1

High‐Density Lipoprotein‐Associated Cholesterol Abnormalities in a Clinical Outcomes Study of Dysferlin‐Deficient Limb–Girdle Muscular Dystrophy Type R2

White, Z. R., Rufibach, L., Dressman, H. G., Hilsden, H., Cox, D., Spuler, S., Day, J., Jones, K., Bharucha-Goebel, D. X., Salort‐Campana, E., et al. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70042 · Cited by 1

Muscle-specific increased expression of JAG1 improves the skeletal muscle phenotype in dystrophin-deficient mice

Leite, F. D. S., Lambert, M. R., Zhang, T., Conner, J. R., Paulo, J. A., Oliveira, S. F., Thakurta, S. G., Bowles, J., Gussoni, E., Gygi, S. P., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2506437122 · Cited by 1

Impaired myogenesis in limb girdle muscular dystrophy type 2B

Souza, L. S., Ishiba, R., Ribeiro-Junior, A. F., Zogbi, I. A., Bouragba, D., Bigot, A., Mouly, V., & Vainzof, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-10205-9 · Cited by 1

Boldo Restores Vascularization and Reduces Skeletal Muscle Inflammation in Symptomatic Mice with Dysferlinopathy

Vásquez, W., Troncoso, F., Lira, A., Escudero, C., & Sáez, J. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209945 · Cited by 1

Peptide-phosphorodiamidate morpholino oligomer therapy for dysferlinopathy induces pseudoexon skipping and restoration of functional protein

Gooding, J. E., Park, G., Wagh, A. A., Watts, J. K., Dominov, J. A., & Brown, R. H. (2026) · JCI Insight · doi:10.1172/jci.insight.204742 · Cited by 1

Modeling muscular diseases by patient-derived iPS cells

Sakurai, H. (2016) · Folia Pharmacologica Japonica · doi:10.1254/fpj.147.272 · Cited by 1

How Plasma Membrane and Cytoskeletal Dynamics Influence Single-Cell Wound Healing: Mechanotransduction, Tension and Tensegrity

Boucher, É. L., Kato, T., & Mandato, C. A. (2016) · InTech eBooks · doi:10.5772/63765 · Cited by 1

Muscular Dystrophies

Kang, P. B., & Kunkel, L. M. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_70 · Cited by 1

Utilization of Targeted RNA-Seq for the Resolution of Variant Pathogenicity and Enhancement of Diagnostic Yield in Dysferlinopathy

Rufibach, L., Berger, K., Chakravorty, S., Emmons, S., Long, L., Gibson, G. C., & Hegde, M. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030520 · Cited by 1

Phenotypic and genotypic analysis of a patient with Miyoshi myopathy caused by truncated protein

Zhou, J., Zhou, R., Feng, Q., Song, X., & Chen, X. (2023) · Gene · doi:10.1016/j.gene.2023.147929 · Cited by 1

Heterogeneous Characteristics of Korean Patients with Dysferlinopathy

Park, H. J., Hong, J., Suh, G. I., Shin, H. Y., Kim, S. M., Sunwoo, I. N., Suh, B. C., & Choi, Y. (2012) · Journal of Korean Medical Science · doi:10.3346/jkms.2012.27.4.424 · Cited by 1

Therapeutic Approaches for Dysferlinopathy in Animal Models

Lostal, W., & Richard, I. (2019) · Springer eBooks · doi:10.1007/978-3-030-03095-7_25 · Cited by 1

Disfunções na motricidade orofacial em pacientes com Distrofia Muscular de Cinturas R2 por deficiência de disferlina

Albuquerque, K. M. D. F., Mota, I. A., Almeida, L. N. A., Golveia, M. L., Souto, P. A. N. G., & Carvalho, A. A. D. S. (2020) · VITTALLE - Revista de Ciências da Saúde · doi:10.14295/vittalle.v32i3.12086 · Cited by 1

АНАЛИЗ ПОЛИМОРФИЗМА ГЕНА ДИСФЕРЛИНА У ГЕНОФОНДНЫХ ПОРОД КУР

Всероссийский НИИ генетики и разведения сельскохозяйственных животных, Ф. Ф. Ф. Ж. —. В. И. А. Л. К. Э., & БАРКОВА, O. Ю. (2021) · Sel skokhozyaistvennaya Biologiya · doi:10.15389/agrobiology.2021.4.641rus · Cited by 1

Expanding the Clinical and Genetic Spectrum of Caveolinopathy in Korea

Lee, S., Kim, S. Y., Lim, B. C., Kim, K. J., Chae, J., & Cho, A. (2022) · Annals of Child Neurology · doi:10.26815/acn.2022.00136 · Cited by 1

The scientific basis of muscle disease

Karpati, G. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.005 · Cited by 2

CNS resilience in the progression of MS

Giovannoni, G., Hawkes, C. H., Lechner‐Scott, J., Levy, M., & Yeh, E. A. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104937 · Cited by 1

Impaired metabolism in X-linked muscular dystrophy: experimental evaluation of potential therapies to improve calcium regulation, bioenergetics and muscle architecture

Rybalka, E. (2007) · Victoria University Research Repository (Victoria University) · Cited by 1

Plasma Membrane Proteins: Dysferlin, Caveolin, PTRF/Cavin, Integrin α7, and Integrin α9

Straub, V. W., DeWaele, L., & Barresi, R. (2013) · Wiley eBooks · doi:10.1002/9781118635469.ch10 · Cited by 1

The Myopathic Protein Myotilin in Developing Mouse and in Muscle Function

Mologni, L. (2009) · Työväentutkimus Vuosikirja · Cited by 1

Disease models and mechanisms in the classroom

Gitler, A. D. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.002600 · Cited by 1

Identification of Skeletal Muscle Mutations in Tail Snips from Neonatal Mice Using Immunohistochemistry

Lovering, R. M., O’Neill, A., Roche, J. A., & Bloch, R. J. (2007) · BioTechniques · doi:10.2144/000112489 · Cited by 1

Contribution of Dysferlin-Containing Membranes to Membrane Repair in Skeletal Muscle.

McDade, J. R. (2014) · Deep Blue (University of Michigan) · Cited by 1

Can a Newer MR Contrast Agent Be Used to Monitor Disease Progression in Muscular Dystrophy?

Unger, E. C. (2008) · Radiology · doi:10.1148/radiol.2501081665 · Cited by 1

Lysosome Exocytosis and Membrane Repair

Singh, R. K., & Haka, A. S. (2016) · Wiley eBooks · doi:10.1002/9781118978320.ch5 · Cited by 1

Dysferlin in skeletal and heart muscle: from trafficking to therapy

Bersch, K. (2017) · doi:10.53846/goediss-6492 · Cited by 1

Calcium | Calcium-Binding Proteins: Cytosolic (Annexins, Gelsolins, and C2-Domain Proteins)

Krebs, J. J. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819460-7.00104-3 · Cited by 1

Duchenne muscular dystrophy is associated with defective membrane repair and dysregulation of annexin-A1/A2 in skeletal musclePreprint

Quang, M. L., d'Agata, L., Carmeille, R., Rassinoux, P., Ruiz, J., Koenig, C., Gounou, C., Salesses, A., Bouvet, F., Sasso, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.23.677988 · Cited by 1

Dysferlin and its role in the pathogenesis of muscular dystrophy

Hofhuis, J. (2013) · doi:10.53846/goediss-4183 · Cited by 1

Nonsecretory, Regulated Exocytosis

Cocucci, E., & Meldolesi, J. (2008) · Springer eBooks · doi:10.1007/978-0-387-39961-4_10

Die experimentelle Pankreatitis beginnt mit einem Loch in der Wand

Müller, M. W., Büchler, P., McNeil, P. L., Beger, H. G., Büchler, M. W., Bockman, D. E., Ceyhan, G., & Friess, H. (2008) · Langenbecks Archiv für Chirurgie. Supplement · doi:10.1007/978-3-540-78833-1_58

The role of tryptophan-rich basic protein (WRB) in inner hair cell synaptic transmission and hearing

Panou, I. (2014) · doi:10.53846/goediss-3940

Biophysical Characterization of Mitsugumin 53 Protein

Nandkumar, R. (2013) · ThinkTech (Texas Tech University)

Intra- und extrazelluläre Vesikelbildung nach Zellschädigung

Pfeiler, S. (2010) · doi:10.5282/edoc.12552

Genome-wide expression analysis comparing hypertrophic changes in normal and dysferlinopathy mice

Lee, Y., Talbot, C. C., & Lee, S. (2015) · Genomics Data · doi:10.1016/j.gdata.2015.10.010

Создание рекомбинантного аденовируса, кодирующего кодон-оптимизированный ген дисферлина, и анализ экспрессии рекомбинантного белка в культуре клеток in vitro

Старостина, И. Г., Соловьева, В. В., Shevchenko, K. G., Deev, R. V., Isaev, A. A., & Rizvanov, A. A. (2012) · zvestiya of the National Academy of Sciences of Belarus (National Academy of Sciences of Belarus)

Test 1: Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial

Lewis, J., Bacall, L., Bogart, H., & Kelly, G. (2015) · Gene · doi:10.1016/s0378-1119(15)30104-4

Kiss and patch up

Pickett, J. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2031

P4 Pathophysiology of anoctaminopathy (LGMD2L)

Kirk, C., Lochmüller, H., Bushby, K. M. D., & Laval, S. H. (2014) · Neuromuscular Disorders · doi:10.1016/s0960-8966(14)70020-3

Dysferlinopathy: Clinical aspects in India

Hattori, H., & Suzuki, N. (2008) · Neurology India · doi:10.4103/0028-3886.43458

Illuminating regeneration: noninvasive imaging of disease progression in muscular dystrophy

Levy, J. R., & Campbell, K. P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69568

Non-invasive protein analysis in the first dysferlinopathy Croatian families

Milić, A., Malnar, M., & Canki‐Klain, N. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0028-z

T CELL SUBSETS AND DISEASE MECHANISMS IN INFLAMMATORY MYOPATHIES

Pandya, J. M. (2014) · Figshare

Dysferlin Expression in Skeletal muscles of Patients with Myopathy and Cultured Human Myoblast/Myotube

Lee, E. Y., & Choi, Y. (2007)

Дисферлинопатии: проблема за пределами дистальных миопатий

Urtizberea, J. A. (2012) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.17650/2222-8721-2012-0-2-20-28

Large-Mediated Glycosylation of Dystroglycan in Skeletal Muscle Function.

Gumerson, J. (2012) · Deep Blue (University of Michigan)

Health Sciences Research Commons

Cuadrado, E., van Hamme, J. L., & van Dort, K. A. (2012)

Unifying Disease Mechanisms; Looking at Similarities and Differences

(2012) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000e109

Molekulare Diagnostik der Dysferlinopathie

Brandt, T. (2005)

Screening two mutations in the dysferlin gene by exon capture and sequence analysis: A case report

Wang, X., Yang, Y., & Zhou, R. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3332

Communication in Membrane Repair

Mahling, R. W. (2015) · University of Minnesota Digital Conservancy (University of Minnesota)

Disferlinopatías: nuevos aspectos diagnósticos y terapéuticos

Díaz‐Manera, J. (2013) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona)

membrane repair zipper motif is essential for MG53-mediated cell Redox-dependent oligomerization through a leucine

Hwang, M., Ko, J., Weisleder, N. L., Takeshima, H., & Ma, J. (2016)

A Young Man with Distal Leg Wasting and Normal Sensation

Bertorini, T. E. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7506-7332-7.50085-4

Therapeutic Approach of iPS Cell Technology for Treating Muscular Dystrophy

Sakurai, H. (2016) · Springer eBooks · doi:10.1007/978-4-431-55678-7_9

Novel genetic defects in titinopathies and other muscular dystrophies

Evilä, A. (2016) · Työväentutkimus Vuosikirja

Models of Epsilon-Sarcoglycan Gene Inactivation and their Implications for the Pathology of Myoclonus Dystonia

Given, A. (2013) · uO Research (University of Ottawa) · doi:10.20381/ruor-6446

PEROXISOME PROLIFERATION IN THE YEAST SACCHAROMYCES CEREVISIAE AND FUNCTIONAL ANALYSIS OF THE MEMBRANE PROTEIN PEX30P

der Diplomarbeit, T. (2011)

Peroxins: A Proliferation Romance amongst Supposition and Disposition

Brocard, C., & Hartig, A. (2007)

Green tea extract and epigallocatechin gallate decrease muscle pathology and NF-κB immunostaining in regenerating muscle fibers of mdx mice

Evans, N. P. (2009) · VTechWorks (Virginia Tech)

Wrecking Repair

(2003) · Science · doi:10.1126/science.300.5624.1343a

Patching Things Up

(2003) · Science Signaling · doi:10.1126/scisignal.1822003tw184 · Cited by 1

Repairing the tears: dysferlin in muscle membrane repair.

Doherty, K. R., & McNally, E. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00136-9 · Cited by 81

Dysferlin and the plasma membrane repair in muscular dystrophy

Bansal, D., & Campbell, K. P. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.03.001 · Cited by 333

Dysferlin in Membrane Trafficking and Patch Repair

Glover, L. E., & Brown, R. H. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00573.x · Cited by 170